Trial record 2 of 197817 for:    ALL

The Effects of RPL554 on Top of Standard COPD Reliever Medications

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified September 2015 by Verona Pharma plc
Sponsor:
Information provided by (Responsible Party):
Verona Pharma plc
ClinicalTrials.gov Identifier:
NCT02542254
First received: August 30, 2015
Last updated: September 3, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)